drugset

drugset / Trial / NCT02249312

The Effect of BIIL 284 BS on Induced-sputum Variables in Patients With Bronchial Asthma

NCT02249312 ↗

Phase 2 Completed 38 enrolled Boehringer Ingelheim

RandomizedParallel-groupDouble-blindTreatment

Summary

Study to evaluate the anti-inflammatory effect of BIIL 284 BS compared with placebo in patients with asthma

Timeline

Start: 1999-07
Primary completion: 2000-04
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AMELUBANT	Small molecule	—	—

Indications